October 21, 2015 / 5:49 PM / 2 years ago

BUZZ-Concordia Healthcare Corp: Down after completing Amdipharm buy

1 Min Read

** Drug developer's U.S-listed shares slumps 30 pct to a 18-month low of $19.09 after company closes acquisition of Amdipharm Mercury Ltd

** Stock is on track for its worst day ever in heavy trading

** Canada's Concordia agreed to buy Amdipharm from PE firm Cinven last month for $1.9 bln ($3.3 bln, including debt)

** Amdipharm buys off-patent drugs from big pharma such as Novartis, GSK and Abbott and sells them in about 100 countries

** About 1.8 mln Concordia shares traded, more than 4 times their 25-day moving avg

** Up to Tuesday's close, stock had fallen 68 pct since it announced the acquisition of Amdipharm on Sept. 8

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below